2-151814213-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_012097.4(ARL5A):c.211G>C(p.Glu71Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000275 in 1,454,880 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012097.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL5A | NM_012097.4 | c.211G>C | p.Glu71Gln | missense_variant | Exon 3 of 6 | ENST00000295087.13 | NP_036229.1 | |
ARL5A | NM_001037174.2 | c.100G>C | p.Glu34Gln | missense_variant | Exon 3 of 6 | NP_001032251.1 | ||
ARL5A | NM_177985.3 | c.100G>C | p.Glu34Gln | missense_variant | Exon 3 of 6 | NP_817114.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL5A | ENST00000295087.13 | c.211G>C | p.Glu71Gln | missense_variant | Exon 3 of 6 | 1 | NM_012097.4 | ENSP00000295087.8 | ||
ENSG00000283228 | ENST00000637559.1 | n.*497G>C | downstream_gene_variant | 5 | ENSP00000489697.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000122 AC: 3AN: 245690Hom.: 0 AF XY: 0.00000752 AC XY: 1AN XY: 133050
GnomAD4 exome AF: 0.00000275 AC: 4AN: 1454880Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 723820
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.211G>C (p.E71Q) alteration is located in exon 3 (coding exon 3) of the ARL5A gene. This alteration results from a G to C substitution at nucleotide position 211, causing the glutamic acid (E) at amino acid position 71 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at